Biogen says Aduhelm reduces Alzheimer's indicators in long-term trial

(Reuters) -Biogen Inc said on Wednesday patients in a long-term trial of its Alzheimer's drug Aduhelm experienced reductions in two key disease indica...

Related Keywords

Bengaluru ,Karnataka ,India ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Manojna Maddipatla ,Maju Samuel ,Biogen Inc ,International Conference On Alzheimer ,Reuters ,International Conference , ,